🇺🇸 Use of bromfenac 0.09% to reduce intravitreal injection pain in United States

Use of bromfenac 0.09% to reduce intravitreal injection pain (Use of bromfenac 0.09% to reduce intravitreal injection pain) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Use of bromfenac 0.09% to reduce intravitreal injection pain in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Use of bromfenac 0.09% to reduce intravitreal injection pain approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Use of bromfenac 0.09% to reduce intravitreal injection pain in United States?

Wills Eye is the originator. The local marketing authorisation holder may differ — check the official source linked above.